Clinical Report: Assessing Outreach Strategies for Genetic Testing Participation
Overview
This study evaluates the effectiveness of different outreach methods and clinic workflows on genetic testing participation among high-risk patients. Despite outreach efforts, genetic testing rates remained low, highlighting the need for improved access and integration into routine care.
Background
Genetic testing is crucial for precision medicine, particularly in identifying hereditary cancer risks. However, participation rates among eligible patients are alarmingly low, with significant disparities based on race, age, and insurance status. Understanding effective outreach strategies is essential to enhance testing uptake and reduce health disparities.
Data Highlights
Outreach Method
Participation Rate
Mailed Brochure
Low
Email
Low
SMS Text Message
Low
Same Building Workflow
Higher
Different Building Workflow
Lower (IRR = 0.72)
Key Findings
Less than 3% of high-risk patients participated in genetic testing following outreach.
No significant difference in participation rates was observed among different outreach methods.
Patients offered testing in the same building had higher order rates compared to those required to go to a different building.
Disparities in order rates were more pronounced in the different building workflow.
Low-cost outreach methods, such as email, are feasible despite low engagement.
Point-of-care access is critical for improving participation and equity in genetic testing.
Clinical Implications
Healthcare systems should prioritize same-day genetic testing and enhance provider capacity to facilitate access. Integrating genetic testing into routine care, such as during mammography, may help bridge existing gaps in participation.
Conclusion
The study underscores the importance of effective outreach and workflow strategies in increasing genetic testing participation among high-risk patients. Continued efforts are needed to improve access and reduce disparities in genetic testing.
